Robuta

Sponsored by eBay https://www.biospace.com/press-releases/arialys-therapeutics-publishes-preclinical-data-in-nature-communications-supporting-art5803-as-a-first-in-class-precision-therapeutic-for-anti-nmda-receptor-autoimmune-neuropsychiatric-disease Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a... preclinical data https://www.globenewswire.com/news-release/2025/03/26/3050114/0/en/Rani-Therapeutics-Announces-Preclinical-Data-Demonstrating-Bioequivalence-of-RT-114-a-GLP-1-GLP-2-Dual-Agonist-PG-102-Delivered-Orally-via-the-RaniPill-Capsule-to-Subcutaneously-Ad.html Rani Therapeutics Announces Preclinical Data Demonstrating - RT-114 yielded a relative bioavailability of 111% compared to PG-102 delivered subcutaneously with comparable PK profiles, meeting the primary endpoint... preclinical dataranitherapeuticsannouncesdemonstrating https://www.biospace.com/gri-bio-presents-positive-preclinical-data-demonstrating-lead-program-gri-0621-reduces-the-important-inflammatory-and-fibrotic-drivers-in-idiopathic-pulmonary-fibrosis-ipf GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the... May 20, 2024 - GRI Bio, Inc. today presented positive preclinical data demonstrating its lead program GRI-0621 reduces the important inflammatory and fibrotic drivers in... preclinical data https://www.globenewswire.com/news-release/2017/12/11/1250669/0/en/Preclinical-Data-Supporting-Wave-Life-Sciences-ALS-and-FTD-Programs-Presented-at-28th-International-Symposium-on-ALS-MND.html Preclinical Data Supporting Wave Life Sciences ALS and FTD Lead candidate targets C9ORF72; in vivo animal data demonstrate potent, sustained and preferential knockdown of toxic biomarkers associated with ALS and... preclinical datalife sciencessupportingwaveals https://www.globenewswire.com/news-release/2025/05/16/3082930/0/en/Shape-Therapeutics-Presents-Preclinical-Data-Highlighting-Therapeutic-Potential-of-RNA-Editing-and-AAV-Delivery-Platforms-at-the-American-Society-of-Gene-and-Cell-Therapy-28th-Annu.html Shape Therapeutics Presents Preclinical Data Highlighting Industry-leading RNA editing activity in the CNS of both mice and non-human primates highlights the broad applicability and therapeutic potential of the... preclinical datashapetherapeuticspresentshighlighting https://www.biospace.com/mersana-therapeutics-reports-preclinical-data-from-immunosynthen-sting-agonist-adc-platform-and-pipeline Mersana Therapeutics Reports Preclinical Data from Immunosynthen STING-Agonist ADC Platform and... Nov 11, 2020 - Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... preclinical data https://www.prnewswire.com/news-releases/whitehawk-therapeutics-presents-comprehensive-preclinical-data-highlighting-its-next-generation-adc-portfolio-at-the-aacr-2026-302746115.html Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC... /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established... preclinical datanext generationwhitehawktherapeuticspresents https://www.biospace.com/press-releases/pliant-therapeutics-presents-clinical-and-preclinical-data-at-the-american-thoracic-society-international-conference Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society... preclinical data https://finviz.com/news/345555/zentalis-pharmaceuticals-to-present-azenosertib-preclinical-data-in-triple-negative-breast-cancer-and-real-world-analysis-of-unmet-need-in-cyclin-e1-positive-ovarian-cancer-at-aacr-2026 Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer... Stock screener for investors and traders, financial visualizations. preclinical data https://investingnews.com/new-clinical-and-preclinical-data-for-investigational-candidate-zidesamtinib-presented-at-aacr-annual-meeting-2026/ New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR... Apr 17, 2026 - Zidesamtinib demonstrated meaningful clinical activity in subset of TKI pre-treated ROS1-positive NSCLC patients from ARROS-1 trial previously treated with... preclinical data https://investingnews.com/nurix-therapeutics-announces-new-preclinical-data-highlighting-breadth-of-targeted-protein-degradation-pipeline-at-aacr-2026/ Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein... Apr 22, 2026 - Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programs Presentations reinforce potential of degraders to overcome... preclinical datatherapeuticsannouncesnew https://www.biospace.com/vistagen-reports-positive-preclinical-data-differentiating-mechanism-of-action-of-ph94b-from-risk-ridden-benzodiazepines VistaGen Reports Positive Preclinical Data Differentiating Mechanism of Action of PH94B from... Nov 12, 2020 - VistaGen Therapeutics (NASDAQ: VTGN), today announced new in vitro electrophysiology data demonstrating that the mechanism of action of PH94B, the intranasal... mechanism of actionpreclinical datareportspositive https://www.globenewswire.com/news-release/2024/03/28/2853896/0/en/Theratechnologies-to-Present-Preclinical-Data-at-AACR-on-Multiple-PDCs-Showcasing-Potential-of-SORT1-Technology-Platform.html Theratechnologies to Present Preclinical Data at AACR on Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers Separate data to highlight activity of... preclinical datapresentaacr https://www.biospace.com/shasqi-announces-publication-of-preclinical-data-demonstrating-proof-of-principle-for-click-activated-approach-to-cancer-treatment Shasqi Announces Publication of Preclinical Data Demonstrating Proof-of-Principle for... Jan 27, 2021 - Shasqi, a clinical-stage biotechnology company developing precision oncology therapeutics with its proprietary Click Activated Protodrugs Against Cancer... preclinical dataannouncespublicationdemonstratingproof https://investingnews.com/prelude-therapeutics-presents-preclinical-data-from-development-candidate-prt13722-a-first-in-class-orally-bioavailable-potent-and-highly-selective-kat6a-degrader-at-american-association-for-cancer-re/ Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a... Apr 20, 2026 - Data Demonstrate Potential for Differentiated Efficacy and Safety Profile, Including Complete Responses as Monotherapy in Multiple CDX and PDX Models of... preclinical datapreludetherapeuticspresentsdevelopment https://www.biospace.com/silverback-therapeutics-announces-presentation-of-preclinical-data-at-asco-supporting-potential-clinical-activity-of-sbt6050-as-a-single-agent-and-in-combination-with-trastuzumab-for-the-treatment-of-her2-expressing-malignancies Silverback Therapeutics Announces Presentation of Preclinical Data at ASCO Supporting Potential... Jun 1, 2020 - Silverback Therapeutics, a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered, but locally active, announced that... preclinical datasilverbacktherapeuticsannouncespresentation https://www.businesswire.com/news/home/20221106005099/en/OliX-Pharmaceuticals-Announces-Positive-Preclinical-Data-in-NASH-Non-human-Primate-Models?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT OliX Pharmaceuticals Announces Positive Preclinical Data in NASH Non-human Primate Models OliX has secured positive effects of OLX702A, an investigational GalNAc-asiRNA therapeutics for the treatment of nonalcoholic steatohepatitis (NASH). non human primatepreclinical data https://www.benzinga.com/general/biotech/23/04/31895244/ambrx-biopharma-highlights-preclinical-data-from-studies-in-kidney-prostate-cancer Ambrx Biopharma Highlights Preclinical Data From Studies in Kidney, Prostate Cancer - Benzinga preclinical data https://investingnews.com/monte-rosa-therapeutics-presents-preclinical-data-at-american-association-for-cancer-research-annual-meeting-2026-on-the-potential-of-its-cyclin-e1-directed-molecular-glue-degrader-to-treat-ccne1-ampl/ Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research... Apr 20, 2026 - CCNE1-directed molecular glue degrader (MGD) induced deep tumor regressions in CCNE1-amplified in vivo models of ovarian, breast, and gastric cancers... monte rosapreclinical data https://www.biospace.com/telik-inc-announces-preclinical-data-demonstrating-anti-cancer-activity-of-dual-inhibitors-of-aurora-kinase-and-vegfr2 Telik, Inc. Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of... telik incpreclinical data https://www.globenewswire.com/fr/news-release/2025/11/04/3180398/0/en/Compass-Therapeutics-Presents-Preclinical-Data-on-CTX-10726-a-Differentiated-PD-1-x-VEGF-A-Bispecific-Antibody-at-the-40th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html Compass Therapeutics Presents Preclinical Data on CTX-10726 demonstrated potent, simultaneous inhibition of tumor angiogenesis and PD-1-mediated immune suppression, and eliminated tumors in multiple... preclinical datacompasstherapeuticspresents https://www.businesswire.com/news/home/20210218006082/en/Sensorion-Presents-New-Preclinical-Data-on-SENS-401-at-ARO-2021 Sensorion Presents New Preclinical Data on SENS-401 at ARO 2021 Sensorion presents new preclinical data on SENS-401 at ARO 2021 preclinical datapresentsnew https://menafn.com/1111067193/Valitor-Presents-Preclinical-Data-Demonstrating-Superior-Durability-With-Six-Month-Treatment-Protocol-Of-VLTR-559-To-Treat-Wet-AMD Valitor Presents Preclinical Data Demonstrating Superior Durability With Six-Month Treatment... Valitor Presents Preclinical Data Demonstrating Superior Durability With Six-Month Treatment Protocol Of VLTR-559 To Treat Wet AMD. VLTR-559 demonstrates... preclinical datavalitorpresentsdemonstrating https://finviz.com/news/345690/monte-rosa-therapeutics-presents-preclinical-data-at-american-association-for-cancer-research-aacr-annual-meeting-2026-on-the-potential-of-its-cyclin-e1-ccne1-directed-molecular-glue-degrader-to-treat-ccne1-amplified-solid-tumors Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research... Stock screener for investors and traders, financial visualizations. monte rosapreclinical data https://www.biospace.com/oric-pharmaceuticals-presents-preclinical-data-on-glucocorticoid-receptor-antagonist-at-2019-san-antonio-breast-cancer-symposium ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist at 2019 San... Dec 16, 2019 - ORIC-101 robustly inhibits the glucocorticoid pathway and overcomes chemoresistance in triple-negative breast cancer preclinical data https://www.biospace.com/purespring-therapeutics-presents-preclinical-data-at-the-61st-era-congress Purespring Therapeutics presents preclinical data at the 61st ERA Congress - BioSpace May 27, 2024 - Purespring Therapeutics is presenting preclinical data at the 61st European Renal Association Congress, showing that transgenes can be efficiently targeted to... preclinical datatherapeuticspresents https://www.biospace.com/press-releases/pilatus-biosciences-publishes-preclinical-data-in-cancer-discovery-on-plt012-first-in-class-cd36-targeting-antibody-for-liver-cancer Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class... preclinical data https://www.biospace.com/five-prime-therapeutics-presents-preclinical-data-demonstrating-potent-anti-tumor-activity-with-fpt155 Five Prime Therapeutics Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity With... preclinical data https://www.biospace.com/renagade-therapeutics-to-present-preclinical-data-demonstrating-potent-extra-hepatic-delivery-of-mrna-using-proprietary-lipid-nanoparticles-at-11th-international-mrna-health-conference ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of... Oct 30, 2023 - ReNAgade Therapeutics today announced it will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-based delivery of mRNA to... preclinical data https://www.biospace.com/press-releases/atea-pharmaceuticals-announces-presentation-of-bemnifosbuvir-preclinical-data-at-the-38th-international-conference-on-antiviral-research-icar-2025 Atea Pharmaceuticals Announces Presentation of Bemnifosbuvir Preclinical Data at the 38th... preclinical dataateapharmaceuticalsannouncespresentation https://www.biospace.com/capsida-biotherapeutics-to-present-new-preclinical-data-on-potential-of-systemically-delivered-next-generation-aav-therapeutics-for-treatment-of-genetic-epilepsy Capsida Biotherapeutics to Present New Preclinical Data on Potential of Systemically Delivered... Jun 2, 2023 - Capsida Biotherapeutics ("Capsida") today announced it will present new preclinical data showing the potential for its engineered adeno-associated virus (AAV)... preclinical data https://www.biospace.com/angiotech-pharmaceuticals-inc-release-positive-preclinical-data-on-vascular-wrap-tm-presented-at-vascular-conference-112051 Angiotech Pharmaceuticals, Inc. Release: Positive Preclinical Data On Vascular Wrap(TM) Presented... angiotech pharmaceuticals incpreclinical data https://www.businesswire.com/news/home/20240402710975/en/Kelonia-Therapeutics-to-Present-Preclinical-Data-Highlighting-Therapeutic-Potential-of-in-vivo-CAR-T-Cell-Therapy-in-Multiple-Myeloma Kelonia Therapeutics to Present Preclinical Data Highlighting Therapeutic Potential of in vivo... Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced new preclinical data from its lead program KLN-1010, which wil... preclinical data https://www.biospace.com/athira-pharma-announces-publication-of-preclinical-data-highlighting-fosgonimeton-treatment-in-models-of-alzheimer-s-disease Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in... Jul 17, 2024 - Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow... athira pharmapreclinical dataannouncespublication https://www.biospace.com/roche-presents-positive-preclinical-data-on-genmab-antibody Roche Presents Positive Preclinical Data On Genmab Antibody - BioSpace preclinical datarochepresentspositivegenmab https://www.biospace.com/hoth-therapeutics-announces-top-line-preclinical-data-from-cutaneous-lupus-erythematosus-cle-study Hoth Therapeutics Announces Top Line Preclinical Data from Cutaneous Lupus Erythematosus (CLE)... Apr 21, 2020 - Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced top line data from its Cutaneous Lupus Erythematosus (CLE) study, a... cutaneous lupus erythematosustop linepreclinical data https://www.businesswire.com/news/home/20240501555976/en/Avilar-Therapeutics-to-Present-Preclinical-Data-for-MTAC-M6PR-Targeting-Chimera-Extracellular-Protein-Degrader-Platform-at-the-American-Association-of-Immunologists-Annual-Meeting Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular... Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced it will present preclinical proof-of-concept d... preclinical data https://www.prnewswire.com/news-releases/dynacure-to-present-preclinical-data-on-disease-progression-modelling-and-aso-mediated-dynamin-2-knockdown-at-world-muscle-society-wms-meeting-301378590.html Dynacure to Present Preclinical Data on Disease Progression Modelling and ASO-Mediated Dynamin 2... /PRNewswire/ -- Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare... https://www.finanznachrichten.de/nachrichten-2026-03/67982771-alzecure-pharma-alzecure-presents-new-preclinical-data-with-neurorestore-acd856-at-the-alzheimer-s-conference-ad-pd-200.htm AlzeCure Pharma: AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at the Alzheimer's... STOCKHOLM, SE / ACCESS Newswire / March 19, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for...